Fig. 2
From: Immunological classification of gliomas based on immunogenomic profiling
Comparisons of immune signatures between three glioma immune subtypes. Immune scores calculated by ESTIMATE [19] (a), the expression levels of HLA genes (b), interferon response scores (c), amplification frequencies of cytokine and cytokine receptor genes (d), ratios of immune-promoting/immune-inhibiting signatures (CD8+/CD4+ regulatory T cells and M1/M2 macrophages) (e), and PD-L1 expression levels (f) were compared between immunity-high, immunity-medium, and immunity-low or between immunity-high and immunity-low subtypes of gliomas. *p < 0.05, **p < 0.01, ***p < 0.001. It also applies to the following figures